It checks today's price at every store, compares the alternatives and answers in about a minute.
Tirzepatide sublingual tablets are a needle-free, once-daily mint-flavored tablet placed under the tongue, positioned as a compounded alternative to injectable tirzepatide. They are marketed to activate GLP-1 and GIP pathways to support appetite control, fullness and weight management, with a step-up dosing plan from a licensed 503A pharmacy. Buyers who like it cite convenience over weekly shots and gentler appetite suppression without jitters. The main caveats are slow dissolution, reported constipation, and effects that some users only noticed in the second month.
In stockReturn policy
Buyers rate it highly and describe easy once-daily use, less late-night snacking and longer fullness, with several preferring it to weekly injections. Complaints center on slow dissolution, constipation and delayed onset.
Tirzepatide is a once-daily, mint-flavored sublingual tablet. It is a GLP-1 and GIP receptor agonist, so it acts on both of those pathways. It is needle-free and dissolves under the tongue.
Each tablet contains 10 mg of tirzepatide. The tablets are round and white, with no artificial colors or dyes. They are compounded by a licensed U.S. 503A pharmacy. The product supports weight loss, fullness and reduced calorie intake, and works with the body's natural hormones rather than as a stimulant or appetite suppressant.
Place 1 tablet under the tongue once daily and let it dissolve fully. Do not chew it or swallow it whole. It can be taken with or without food, at the same time each day. Do not exceed 1 tablet daily unless directed by your provider. A licensed healthcare provider reviews a short medical history form and prescribes the medication if appropriate. Buyers must be 18 or older. Some users may experience nausea, fullness, bloating, mild stomach discomfort or changes in bowel habits.
